UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities... (continue reading...)
PRICING SUPPLEMENT dated September 18, 2026
(To the Prospectus and Prospectus Supplement, each dated
April 17, 2026 and Product Supplement no. WF-1-I dated
April 17, 2026)
Filed Pursuant to Rule 424(b)(2)
Registration Statement Nos. 333-293684 and 333-293684-01
JPMorgan Chase Financial Company LLC
Global Medium-Term Notes, Series A Fully and Unconditionally Guaranteed by JPMorgan Chase &... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): September 16, 2026
Houlihan Lokey, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware 001-37537 95-2770395
(State or... (continue reading...)
More SEC Filings
View Older Stories-
Form 425 Launch Two Acquisition Filed by: NuCube Energy, Inc.
-
Form 424B2 MORGAN STANLEY
-
Form 424B5 Stardust Power Inc.
-
Form 4 i3 Verticals, Inc. For: Sep 20 Filed by: SMITH GEOFFREY C.
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form 6-K MBody AI Ltd. For: Sep 22
-
Form SUPPL Brookfield Finance Inc.
-
Form 424B2 BofA Finance LLC
-
Form 497 iSHARES TRUST
-
Form 4 HENNESSY ADVISORS INC For: Sep 18 Filed by: SEAVEY THOMAS L
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form 4 BIOLIFE SOLUTIONS INC For: Sep 18 Filed by: Mathew Aby J.
-
Form 4 BIOLIFE SOLUTIONS INC For: Sep 18 Filed by: Berard Todd
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 BIOLIFE SOLUTIONS INC For: Sep 18 Filed by: Werner Sean
-
Form 4 BIOLIFE SOLUTIONS INC For: Sep 18 Filed by: DE GREEF RODERICK
-
Form 4 BIOLIFE SOLUTIONS INC For: Sep 18 Filed by: Wichterman Troy
-
Form D Sun Valley Portfolio
-
Form 424B2 UBS AG
-
Form 8-K Stardust Power Inc. For: Sep 22
-
Form 1-A/A Deedflow INC
-
Form 4 HENNESSY ADVISORS INC For: Sep 18 Filed by: Knight ORiordan Lydia D
-
Form 3 BNB PLUS CORP. For: Sep 03 Filed by: Lee Lok
-
Form 8-K Inmune Bio, Inc. For: Sep 08
-
Form 4 Guggenheim Taxable Munic For: Sep 14 Filed by: Li Allen
-
Form 4 Amneal Pharmaceuticals, For: Sep 11 Filed by: BUCHI J KEVIN
-
Form 4 Diamondback Energy, Inc. For: Sep 10 Filed by: Zmigrosky Matt
-
Form 8-K PDS Biotechnology Corp For: Sep 12
-
Form 3 Mobileye Global Inc. For: Sep 03 Filed by: Ohayon Yaacov
-
Form 4 CDW Corp For: Sep 10 Filed by: CONNELLY ELIZABETH H.
-
Form 8-K Parker-Hannifin Corp For: Sep 14
-
Form 4 LA-Z-BOY INC For: Sep 10 Filed by: Sundy Robert II
-
Form 8-K Scienture Holdings, Inc. For: Sep 14
-
Form 144 MOHAWK INDUSTRIES INC Filed by: LORBERBAUM JEFFREY S
-
Form 4 LITHIA MOTORS INC For: Sep 11 Filed by: Loretz Congdon Stacy
-
Form 4 NIO Inc. For: Sep 12 Filed by: Lee Denny Ting Bun
-
Form 4 REDWOOD TRUST INC For: Sep 15 Filed by: Abate Christopher J
-
Form 8-K TEVA PHARMACEUTICAL INDU For: Sep 14
-
Form 8-K FIRST CITIZENS BANCSHARE For: Sep 11
-
Form 4 Jushi Holdings Inc. For: Sep 03 Filed by: Arsenault Denis J.
-
Form 8-K Federal Home Loan Bank For: Sep 09
-
Form 8-K Vaxart, Inc. For: Sep 03
-
Form 3 Veraxa Biotech AG - Post For: Sep 01 Filed by: Willener Raju Sudir
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 144 PACS Group, Inc. Filed by: Hancock Mark
-
Form 8-K Sionna Therapeutics, For: Sep 09
-
Form 4 Smith Douglas Homes Corp For: Sep 10 Filed by: Bradbury Thomas L
-
Form 8-K Contineum Therapeutics, For: Sep 14
-
Form 144 Mineralys Therapeutics, Filed by: Rodman David Malcom

